Sunshine Biopharma Receives Health Canada Approval for Essential Calcium-Vitamin D(TM) Supplement

MONTREAL, QC / ACCESSWIRE / November 6, 2019 / Sunshine Biopharma, Inc. (OTCPINK:SBFM) today announced that it has received Health Canada approval for Essential Calcium-Vitamin D supplement, the second in a line of Essential Micronutrients Products that the Company is planning to launch. Health Canada issued NPN 80093432 through which it authorized Sunshine Biopharma to manufacture and sell a Calcium-Vitamin D supplement under the brand name Essential Calcium-Vitamin D. Essential Calcium-Vitamin D is a dietary supplement tablet that contains a balanced formula of Calcium and Vitamin D complex. Vitamin D plays a major role in multiple biological functions, including regulating the concentration of calcium and phosphate, and promoting the healthy growth and remodeling of bone. In addition, Vitamin D is involved in cell growth, neuromuscular and immune functions, and reduction of inflammation. Sunshine Biopharma anticipates that Essential Calcium-Vitamin D will be available on Amazon.ca in January 2020. The Company’s first Essential Micronutrients Product, Essential 9, launched earlier this year is currently available in Canada on Amazon.ca and in the US on Amazon.com.

About Essential Calcium Vitamin D

Vitamin D is a group of steroid-like molecules responsible for increasing intestinal absorption of calcium, magnesium, and phosphate. They are also involved in multiple other biological functions, including promoting the healthy growth and remodeling of bone, cell growth, neuromuscular and immune functions, and reduction of inflammation. The most important compounds in this group are Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol). Sunshine Biopharma’s Essential Calcium-Vitamin D tablets contain both of these compounds as well as Calcium for optimum health benefits.

About Essential 9

Essential Amino Acids are 9 out of the 20 amino acids required for protein synthesis. Proteins are involved in all body functions – From the musculature and immune system to hormones and neurotransmitters. Like vitamins, Essential Amino Acids cannot be made by the human body and must be obtained through diet. Deficiency in one or more of the 9 Essential Amino Acids can lead to loss of muscle mass, fatigue, weight gain and reduced ability to build muscle mass in athletes. Sunshine Biopharma’s Essential 9 provides all 9 Essential Amino Acids in free-form and in the proportions recommended by Health Canada. Essential 9 is suitable for everyone: vegans, athletes, seniors, dieters. Essential 9 is currently available on Amazon.ca and Amazon.com.

Safe Harbor Forward-Looking Statements

To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company’s development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

For Additional Information:

Sunshine Biopharma, Inc.
Camille Sebaaly, CFO
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com

SOURCE: Sunshine Biopharma Inc.

View source version on accesswire.com:
https://www.accesswire.com/565453/Sunshine-Biopharma-Receives-Health-Canada-Approval-for-Essential-Calcium-Vitamin-DTM-Supplement

Staff

Recent Posts

CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the…

49 mins ago

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on…

50 mins ago

Youth Inventors Compete at The Henry Ford during RTX Invention Convention U.S. Nationals June 5-7, 2024, in Dearborn, Michigan

DEARBORN, Mich., July 8, 2024 /PRNewswire/ -- The Henry Ford hosted over 435 youth inventors…

54 mins ago

Leading Medical Claims Management provider, Medlogix, LLC Announces the Acquisition of ReviewWorks

HAMILTON, N.J., July 8, 2024 /PRNewswire/ -- Medlogix, LLC, a leading, national medical claims management…

54 mins ago

Gymdesk Announces a $32.5 Million Strategic Growth Investment from Five Elms Capital

KANSAS CITY, Mo., July 8, 2024 /PRNewswire/ -- Gymdesk, a leading provider of member management…

54 mins ago

GQR Acquires Uniti Med, Enhancing Workforce Solutions and Expanding Market Reach

NEW YORK, July 8, 2024 /PRNewswire/ -- GQR, a leading global workforce solutions firm, proudly…

54 mins ago